Artiva Biotherapeutics (ARTV) Shares Outstanding (2023 - 2026)

Artiva Biotherapeutics (ARTV) has reported Shares Outstanding (Entity) for 4 consecutive years, with $24.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 1.45% year-over-year to $24.7 million; the TTM figure through Mar 2026 stood at $24.7 million (up 1.45% YoY), while the FY2025 annual figure was $24.6 million, up 118.46% from the prior year.
• Shares Outstanding (Entity) steadied at $24.7 million in Q1 2026 per ARTV's latest filing, from $24.6 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $24.7 million in Q1 2026 and bottomed at $805199.0 in Q2 2023.
• Historically, Shares Outstanding (Entity) has averaged $13.1 million across 4 years, with a median of $15.1 million in 2024.
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) increased 1.12% — and 2025, when it soared 2908.69%.
• Artiva Biotherapeutics' Shares Outstanding (Entity) stood at $809758.0 in 2023, then soared by 1290.4% to $11.3 million in 2024, then soared by 118.46% to $24.6 million in 2025, then climbed by 0.49% to $24.7 million in 2026.
• Business Quant data shows ARTV's Shares Outstanding (Entity) at $24.7 million in Q1 2026, $24.6 million in Q4 2025, and $24.5 million in Q3 2025.